Verition Fund Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Sell
169,103
-22,432
-12% -$236K 0.01% 1081
2025
Q4
$2.01M Sell
191,535
-10,003
-5% -$104K 0.01% 1616
2025
Q3
$2.09M Hold
201,538
0.01% 1938
2025
Q2
$2.08M Sell
201,538
-15,002
-7% -$152K 0.01% 1911
2025
Q1
$2.18M Buy
+216,540
New +$2.18M 0.01% 1510

Other funds holding TDAC

Verition Fund Management's TDAC Position: Q1 2026 in Review

Verition Fund Management reduced its Translational Development Acquisition Corp (TDAC) stake by 12% in Q1 2026, selling an estimated $236K and leaving 169,103 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #1081.

Verition Fund Management first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.18M in Q1 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Verition Fund Management held 169,103 shares of Translational Development Acquisition Corp worth $1.79M as of Q1 2026.
  • Verition Fund Management sold 22,432 Translational Development Acquisition Corp shares in Q1 2026, an estimated $236K.
  • Translational Development Acquisition Corp made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1081 holding.
  • Verition Fund Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Verition Fund Management's Translational Development Acquisition Corp position peaked at $2.18M in Q1 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.